Akari Therapeutics Plc
Officers & Directors
1. Samir Patel - Director: Patel is affiliated with BDO USA, P.C. and has served as the Company’s auditor since his appointment. 2. Wendy DiCicco - Interim Chief Financial Officer: Wendy has taken on the role of Interim Chief Financial Officer for the Company. 3. Michael Grissinger - Director: Grissinger is a member of the Board of Directors. 4. Wael Hashad - Director: Hashad serves on the Board of Directors. 5. Donald Williams - Director: Williams is also a member of the Board of Directors. 6. Rachelle Jacques - President, Chief Executive Officer, and Director: Jacques holds the position of President, Chief Executive Officer, and is a Director on the Board. 7. Dr. Ray Prudo - Chairman: Prudo serves as the Chairman of the Board.,
Akari Therapeutics Plc currently has 6 employees.
News about Akari Therapeutics Plc Key Personnel |
Akari Therapeutics: A Financial Rebirth Amidst Challenges in the Biopharmaceutical LandscapeOverview of Recent DevelopmentsAkari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company specializing in innovative therapies for cancer treatment, has recently made significant movements in its financial and operational strategy. This is exemplified by the successful pricing of a $7.6 million private placement offering led by existing shareholders, aiming to bolster the company’s cash reserves while focusing on its promising pipeline, including the novel spliceosome inhibitor payload antibody-drug conjugate (ADC) technology. However, the backdrop of these achievements features a cumulative net loss of $26 mil...
|
|
